Headquartered in Waltham, MA Fiscal year ends December NASDAQ: MBIO mustangbio.com
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or liquidity,…
Lee Jackson Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.
The Wall Street consensus 12-month price target for MBIO is $10.00.